← Human Trials & Peer-Reviewed Studies
Effects of high dairy protein intake and vitamin D supplementation on body composition and cardiometabolic markers in 6-8-y-old children-the D-pro trial.
Plain-language guide to PMID 35015806 (2022): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 35015806
- Journal
- The American journal of clinical nutrition
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Thams L et al. (6 authors)
- DOI
- 10.1093/ajcn/nqab424
- Registered trial
- NCT03956732
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The researchers investigated combined and separate effects of high dairy protein intake and vitamin D on body composition and cardiometabolic markers in children.
Why It Was Studied
Dairy protein and vitamin D can affect body composition and cardiometabolic markers, yet evidence among well-nourished children is sparse.
Who Took Part
By PubMed's age tags, the people studied were children.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
The researchers measured body composition (by DXA), blood pressure, and fasting blood glucose, insulin, C-peptide, and lipids.
What Was Measured
The subject headings attached to it are Blood Glucose, Body Composition, Cardiovascular Diseases, Cholecalciferol, Dietary Supplements, Vitamin D and Vitamin D Deficiency.
The authors tagged it with the keywords BMI, DXA, FFMI, FMI, blood lipids and cholesterol.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Results are reported in around 11 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2022 (The American journal of clinical nutrition), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.